Glioblastoma is the most common and deadliest form of brain cancer. Patients face a bleak prognosis—the average survival ...

Trials with mice in whom the researchers implanted human glioblastoma cells have already shown that the treatment is very ...

Perioperative chemoimmunotherapy for resectable non-small cell lung cancer (NSCLC) shows promising long-term benefits with ...

Findings, demonstrated by the phase 2 PERLA trial, were presented at the 2024 Society for Immunotherapy of Cancer (SITC ...

Mei Wei, MD, an oncologist specializing in breast cancer at Huntsman Cancer Institute at the University of Utah, discusses new treatments for HR+/HER2- breast cancer and immunotherapy challenges, ...

Opens in a new tab or window While immunotherapy has revolutionized the way in which oncologists treat cancer, its use comes with a variety of side effects ... of immune-related adverse events ...

Related Experimental device aims ... year in the United States -- develop myocarditis as a side effect of the cancer therapy.

which have their own undesired side effects, such as lowering the efficacy of the ICI anti-tumor treatment. One of the more feared complications of immunotherapy, checkpoint myocarditis, is ...

Some patients being treated with immune checkpoint inhibitors, a type of cancer immunotherapy, develop a dangerous form of heart inflammation called myocarditis. Researchers have now uncovered the ...

Recent developments driving growth in this area make the advanced, AI-supported digitization of pharma pipelines inevitable.